Diabetes Core Update
by American Diabetes Association
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 28 chart positions in 28 markets.
By chart position
- 🇺🇸US · Medicine#1525K to 30K
- 🇮🇳IN · Medicine#2630K to 100K
- 🇳🇱NL · Medicine#3130K to 100K
- 🇲🇽MX · Medicine#4830K to 100K
- 🇮🇹IT · Medicine#8810K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
60K to 200K🎙 Daily cadence·100 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
199K to 667K🇮🇳15%🇳🇱15%🇲🇽15%+25 more - Active Followers
Loyal subscribers who consistently listen
60K to 200K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Special Edition: What's Next—Once-Weekly Insulins—Mechanisms and Practical Considerations
Jul 17, 2026
25m 40s
Special Edition: What's Next—CKD in Type 1 Diabetes—An Urgent Need for Therapies
Jul 7, 2026
28m 18s
Efficacy and safety of CagriSema & Retatrutide, CGM benefits beyond T2D, & more!
Jun 30, 2026
34m 30s
Special Edition: Medications in the Pipeline for Cardiometabolic Disease
Jun 25, 2026
25m 10s
Special Edition: The Diabetes, Obesity, and CardioMetabolic CARE Symposium—The Cost of Obesity and Its Treatment
Jun 24, 2026
29m 56s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/17/26 | once-weekly insulinsdiabetes management+3 | Aaron King | American Diabetes AssociationWeekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin+1 | — | once-weekly insulindiabetes+3 | Novo | 25m 40s | ||
| 7/7/26 | chronic kidney diseasetype 1 diabetes+4 | Janet McGill | American Diabetes AssociationChronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026+2 | — | CKDtype 1 diabetes+6 | Bayer | 28m 18s | ||
| 6/30/26 | CagriSemaRetatrutide+4 | — | American Diabetes AssociationEfficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study+4 | — | CagriSemaRetatrutide+6 | — | 34m 30s | ||
| 6/25/26 | cardiometabolic diseasemedications+3 | Dr. Juan Frias | American Diabetes AssociationLos Angeles Institute for Metabolic Research+2 | Thomas Jefferson University | cardiometabolic medicationsdiabetes+3 | Lilly | 25m 10s | ||
| 6/24/26 | obesity treatmenteconomic costs+4 | Timothy Dall, MSMelanie R. Jay, MD+1 | American Diabetes AssociationWeill-Cornell Medical College+4 | — | DiabetesObesity+5 | — | 29m 56s | ||
| 6/10/26 | patient portal messagesolder adults+4 | Anna KahkoskaJoshua Niznik+1 | American Diabetes AssociationQualitative Analysis of Patient Portal Messages From Older Adults With Type 2 Diabetes+1 | — | diabetespatient portal+5 | — | 38m 08s | ||
| 6/2/26 | food coloring additivestype 2 diabetes+5 | — | American Diabetes AssociationFood Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort+5 | — | type 2 diabetesfood coloring+5 | — | 38m 41s | ||
| 5/29/26 | obesity careprimary care+3 | Leigh Perreault | American Diabetes AssociationImplementation and effectiveness of a care process to prioritize weight management in primary care: a stepped-wedge cluster-randomized trial | Sidney Kimmel Medical College, Thomas Jefferson UniversityUniversity of Colorado Denver School of Medicine, Aurora, CO | obesityweight gain+3 | Lilly | 30m 00s | ||
| 5/26/26 | ObesityCardiometabolic diseases+3 | Mikhail Kosiborod | American Diabetes AssociationAmerican Heart Association+1 | — | obesitycardiometabolic diseases+6 | AstraZeneca | 33m 31s | ||
| 5/19/26 | hypercortisolismdiabetes+3 | John Buse | American Diabetes AssociationDiabetes Care | — | hypercortisolismdiabetes+5 | Corcept | 27m 06s |
Showing 10 of 10
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Diabetes Core Update
Peaked at #24 in AE, currently #24 in AE.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| AE | — | #24 | #24 | — |
| CO | — | #24 | #24 | — |
| India | — | #26 | #26 | — |
| Netherlands | — | #31 | #31 | — |
| Finland | — | #34 | #34 | — |
| Ireland | — | #41 | #41 | — |
| CZ | — | #44 | #44 | — |
| SA | — | #45 | #45 | — |
| PT | — | #46 | #46 | — |
| Mexico | — | #48 | #48 | — |
| IS | — | #59 | #59 | — |
| PE | — | #59 | #59 | — |
| IL | — | #63 | #63 | — |
| TW | — | #63 | #63 | — |
| GR | — | #82 | #82 | — |
| Italy | — | #88 | #88 | — |
| TH | — | #91 | #91 | — |
| India | — | #98 | #98 | — |
| KE | — | #117 | #117 | — |
| RO | — | #128 | #128 | — |
Chart Positions
30 placements across 28 markets.
Chart Positions
30 placements across 28 markets.